Real World Study of Deep Venous Thrombosis. Analysis of Prospective Cases in University Hospitals of São Paulo

NCT03388775 | Unknown

• 1 other identifier: DVT 2017
• Study Type: observational
• Target: 800
• Locations: 1 country
• Sites: 1

Brief Summary

Background: Deep venous thrombosis (DVT) is a common and important vascular disease due to its morbidity and mortality. Its incidence remains high throughout the world and constitutes serious problems for national and international public health. Several inherited and/or acquired risk factors may be responsible for thrombus formation. Few epidemiological data regarding real world panorama of this disease in South America and Brazil is available in the literature. Objective: Evaluate demographic data, diagnostic methods and treatment of deep vein thrombosis in the real world in public university hospitals in Brazil. Methods: Five-year prospective records of deep venous thrombosis have been collected by the RHEUNI group of five public schools in the State of São Paulo. Demographic data of patients will be evaluated along with the main risk factors, clinical picture, diagnostic methods, use of different drugs to treat the disease and its complications. Digital platform has been used in data collection. Is a multicenter study and analysis will be performed using Microsoft Excel and Epi-Info. Key words: deep vein thrombosis, assessment, risk factors, demographic data.

Conditions

Registry

Keywords

deep vein thrombosis; assessment; risk factors

Outcome Measures

Primary Outcomes (1)

• Incidence of risk factors for DVT

  1. Inheriting a blood-clotting disorder. 2. Prolonged bed rest, such as during a long hospital stay, or paralysis. 3. Injury or surgery. 4. Pregnancy. 5. Birth control pills (oral contraceptives) or hormone replacement therapy. 6. Being overweight or obese. 7. Smoking. 8. Cancer. 9. Heart failure. 10. Inflammatory bowel disease. 11. A personal or family history of deep vein thrombosis or pulmonary embolism. 12. Age. Being older than 60 increases your risk of DVT.

  Five Years

Secondary Outcomes (1)

• Types of treatment performed in the real world

  Five Years

Study Arms (1)

Patients with deep venous thrombosis

Five-year prospective records of deep venous thrombosis have been collected by the RHEUNI group of five public schools in the State of São Paulo. Demographic data of patients will be evaluated along with the main risk factors, clinical picture, diagnostic methods, use of different drugs to treat the disease and its complications.

Other: deep venous thrombosis

Interventions

deep venous thrombosis OTHER

Five-year prospective analysis of deep venous thrombosis performed by the RHEUNI group of five public schools in the State of São Paulo.

Patients with deep venous thrombosis

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients with venous thrombosis in any site, male or female, regardless of age, with first episode or recurrent episodes and with or without pulmonar embolism.

You may qualify if:

• patients with venous thrombosis in any site, male or female, regardless of age, with first episode or recurrent episodes and with or without pulmonary embolism.

Sponsors & Collaborators

• Fundação Faculdade Regional de Medicina de São José do Rio Preto: lead
• University of Ribeirao Preto: collaborator

Study Sites (1)

Clinics Hospital of Faculty of Medicine of Paulista State University

Botucatu, São Paulo, 18607621, Brazil

RECRUITING

MeSH Terms

Conditions

Venous Thrombosis

Condition Hierarchy (Ancestors)

Thrombosis; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases

Study Officials

• Selma R Raymundo, MD; PhD

  Fundação Faculdade Regional de Medicina de São Jose Do Rio Preto

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Selma R Raymundo, MD; PhD

CONTACT

55 17 996016062; selma_ray@terra.com.br

Edwaldo E Joviliano, MD; PhD

CONTACT

55 16 36021000; eejovilliano@gmail.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 5 Years
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: October 31, 2017
• First Posted: January 3, 2018
• Study Start: July 1, 2013
• Primary Completion: December 1, 2025
• Study Completion: December 1, 2025
• Last Updated: March 12, 2025

Record last verified: 2023-12

Data Sharing

• IPD Sharing: Will not share

Locations

BR (1)